COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,833 Articles (22,553 medRxiv, 8,280 bioRxiv)

Most recent first Previous |  Page 653: Articles 6521-6530  | Next

Temporal profiling of CD4 T-cell activation and differentiation upon SARS-CoV-2 spike protein immunisation
Almeida-Santos, J., Berkachy, R., Tye, C. A., Hassan, J., Kalfaoglu, B., Selkirk, M. E., Ono, M.
10.1101/2022.07.21.500987 — Posted: 2022-07-21
STIMULATE-ICP: A pragmatic, multi-centre, cluster randomised trial of an integrated care pathway with a nested, Phase III, open label, adaptive platform randomised drug trial in individuals with Long COVID: a structured protocol
Forshaw, D., Wall, E. C., Prescott, G., Dehbi, H.-M., Green, A., Attree, E., Hismeh, L., Strain, W. D., Crooks, M. G., Watkins, C., Robson, C., Banerjee, R., Lorgelly, P., Heightman, M., Banerjee, A., the STIMULATE-ICP trial team
10.1101/2022.07.21.22277893 — Posted: 2022-07-21
Geographic and Temporal Patterns in Covid-19 Mortality by Race and Ethnicity in the United States from March 2020 to February 2022
Lundberg, D. J., Cho, A., Raquib, R. V., Nsoesie, E. O., Wrigley-Field, E., Stokes, A. C.
10.1101/2022.07.20.22277872 — Posted: 2022-07-21
National and regional prevalence of SARS-CoV-2 antibodies in primary and secondary school children in England: the School Infection Survey, a national open cohort study, November 2021
Powell, A. A., Ireland, G., Leeson, R., Lacey, A., Ford, B., Poh, J., Ijaz, S., Shute, J., Cherepanov, P., Tedder, R., Bottomley, C., Dawe, F., Mangtani, P., Jones, P., Nguipdop-Djomo, P., Ladhani, S.
10.1101/2022.07.20.22277838 — Posted: 2022-07-21
COVID-19 could cause long term peripheral nerve demyelination and axonal loss: A One Year Prospective Cohort Study
Zhao, Y., Yang, Q., Sun, F., Zhang, M., Lai, Y., Liu, X., Liu, F., Zang, H., Song, J., Li, N., Cui, S., Shao, W., Ma, J., Wang, Z., Cui, L.
10.1101/2022.07.19.22277248 — Posted: 2022-07-21
Risk factors for severe COVID-19 among HIV-infected and-uninfected individuals in South Africa, April 2020- March 2022:data from sentinel surveillance.
Walaza, S., Tempia, S., von Gottberg, A., Wolter, N., Bhiman, J. N., Buys, A., Amoako, D., Moosa, F., du Plessis, M., Moyes, J., McMorrow, M. L., Dawood, H., Variava, E., Reubenson, G., Nel, J., Zar, H. J., Makhasi, M., Meiring, S., Quan, V., Cohen, C.
10.1101/2022.07.20.22277839 — Posted: 2022-07-21
Prevalence and Factors Associated with Mental Illness Symptoms among School Students Post Lockdown of the COVID-19 Pandemic in the United Arab Emirates: A Cross-Sectional National Study
Ghader, N., Al Mheiri, N., Fikri, A., AbdulRazzak, H., Saleheen, H., Saddik, B., Aljawarneh, Y., Dalky, H., Al Banna, A., Al Memari, S., Al Shehhi, B., Al Mazrouei, S., Al Hajeri, O.
10.1101/2022.07.20.22277866 — Posted: 2022-07-21
Mathematical assessment of the role of waning and boosting immunity against the BA.1 Omicron variant in the United States
Safdar, S., Ngonghala, C. N., Gumel, A.
10.1101/2022.07.21.22277903 — Posted: 2022-07-21
Safety and biodistribution of NanoligomersTM targeting SARS-CoV-2 genome for treatment of COVID-19
McCollum, C. R., Courtney, C. M., O'Connor, N. J., Aunins, T. R., Jordan, T. X., Rogers, K., Brindley, S., Brown, J. M., Nagpal, P., Chatterjee, A.
10.1101/2022.07.19.500688 — Posted: 2022-07-20
Evasion of neutralizing antibodies by Omicron sublineage BA.2.75
Sheward, D. J., Kim, C., Fischbach, J., Muschiol, S., Ehling, R. A., Björkström, N. K., Karlsson Hedestam, G. B., Reddy, S. T., Albert, J., Peacock, T. P., Murrell, B.
10.1101/2022.07.19.500716 — Posted: 2022-07-20

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).